Every one of those 2 sits in a single category, earnings. Ameluz is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Source depth averages 2 original sources per story, versus 2.7 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Biofrontera Inc.
Every one of those 2 sits in a single category, earnings. Ameluz is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Source depth averages 2 original sources per story, versus 2.7 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 6.4 in the same window. We currently track 2 Finance stories that mention Biofrontera Inc., all published on March 19, 2026.
Stories tracked
2
Sources per story
2
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 105 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Biofrontera Inc.. Shared-story counts are live from our verified record — not editorial picks.
Biofrontera and DarioHealth reported Q4 2025 results on March 19, 2026, highlighting a strategic shift from aggressive growth to sustainable profitability. While Biofrontera focuses on expanding its dermatology market share with Ameluz, DarioHealth is leveraging its B2B2C model to drive high-margin digital health revenue.
Armanino Foods and Biofrontera Inc. both reported record-breaking fourth-quarter and full-year 2025 financial results on March 19, 2026. These reports highlight strong execution in the specialty food and dermatological pharmaceutical sectors, respectively.
Biofrontera Inc. is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.